Pediatric Neurology
Volume 29, Issue 2 , Pages 124-130 , August 2003

Sickle cell anemia with moyamoya disease: outcomes after EDAS procedure

  • Robert H. Fryer, MD, PhD

      Affiliations

    • Division of Pediatric Neurology, Department of Neurology, College of Physicians and Surgeons, Columbia University, New York, NY, USA
    • Corresponding Author InformationCommunications should be addressed to:Dr. Fryer; The Neurologic Institute; Box 93, 710 West 168th Street; New York, NY 10032, USA.
    • ,
  • Richard C. Anderson, MD

      Affiliations

    • Department of Neurosurgery, College of Physicians and Surgeons, Columbia University, New York, NY, USA
    • ,
  • Claudia A. Chiriboga, MD, MPH

      Affiliations

    • Harlem Hospital Center, New York, New York, USA.
    • ,
  • Neil A. Feldstein, MD

      Affiliations

    • Division of Pediatric Neurology, Department of Neurology, College of Physicians and Surgeons, Columbia University, New York, NY, USA
    • Department of Neurosurgery, College of Physicians and Surgeons, Columbia University, New York, NY, USA

Received 29 October 2002 ,Accepted 21 January 2003.

References 

  1. Ohene-Frempong K, Weiner SJ, Sleeper LA, et al.  Cerebrovascular accidents in sickle cell disease (Rates and risk factors). Blood. 1998;91:288–294
  2. Powars D, Imbus C. Cerebral vascular accidents in sickle cell anemia. Tex Rep Biol Med. 1980;40:293–304
  3. Pavlakis SG, Prohovnik I, Piomelli S, DeVivo DC. Neurologic complications of sickle cell disease. Adv Pediatr. 1989;36:247–276
  4. Drew JM, Scott JA, Chua GT. General case of the day. Moyamoya disease in a child with sickle cell disease. Radiographics. 1993;13:483–484
  5. Stockman JA, Nigro MA, Mishkin MM, Oski FA. Occlusion of large cerebral vessels in sickle-cell anemia. N Engl J Med. 1972;287:846–849
  6. Merkel KH, Ginsberg PL, Parker JC, Post MJ. Cerebrovascular disease in sickle cell anemia (A clinical, pathological and radiological correlation). Stroke. 1978;9:45–52
  7. Garza-Mercado R. Pseudomoyamoya in sickle cell anemia. Surg Neurol. 1982;18(6):425–431
  8. Ramsewak W, Gill G, Lo R. Moyamoya in sickle cell disease demonstrated by DSA and Hexabrix. J Can Assoc Radiol. 1985;36:332–333
  9. Mendelowitsch A, Sekhar LN, Clemente R, Shuaib A. EC-IC bypass improves chronic ischemia in a patient with moyamoya disease secondary to sickle cell disease (An in vivo microdialysis study). Neurol Res. 1997;19:66–70
  10. Fukui M. Current state of study on moyamoya disease in Japan. Surg Neurol. 1997;47:138–143
  11. Chaudari K, Edwards R. Adult moyamoya disease. BMJ. 1993;307:852–854
  12. Numaguchi Y, Balsys R, Marc JA, O’Brien MS. Some observations in progressive arterial occlusions in children and young adolescents ((Moyamoya disease)). Surg Neurol. 1976;6:293–300
  13. Solomon GE, Hilal SK, Gold AP, Carter S. Natural history of acute hemiplegia of childhood. Brain. 1970;93:107–120
  14. Suzuki J, Takaku A. Cerebrovascular “moyamoya” disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol. 1969;20:288–299
  15. Levine SR, Fagan SC, Pessin MS, et al.  Accelerated intracranial occlusive disease, oral contraceptives, and cigarette use. Neurology. 1991;41:1893–1901
  16. Poor G, Gacs G. The so-called ‘moyamoya disease’. J Neurol Neurosurg Psychiatry. 1974;37:370–377
  17. Cohen N, Berant M, Simon J. Moyamoya and Fanconi’s anemia. Pediatrics. 1980;65:804–805
  18. Vernet O, Montes JL, O’Gorman AM, Baruchel S, Farmer JP. Encephaloduroarterio-synangiosis in a child with sickle cell anemia and moyamoya disease. Pediatr Neurol. 1996;14:226–230
  19. Gordon N, Isler W. Childhood moyamoya disease. Dev Med Child Neurol. 1989;31:103–107
  20. Goldstein EM, Singer HS. Moyamoya-like disease in Down’s syndrome. Pediatr Neurosurg. 1990;16:14–16
  21. Dai AI, Shaikh ZA, Cohen ME. Early-onset Moyamoya syndrome in a patient with Down syndrome (Case report and review of the literature). J Child Neurol. 2000;15:696–699
  22. Adams RJ, McKie VC, Hsu L, et al.  Prevention of first stroke by transfusion in children with sickle cell anemia and abnormal results on transcranial doppler ultrasonography. N Engl J Med. 1998;339:5–11
  23. Pegelow CH, Adams RJ, McKie V, et al.  Risk of recurrent stroke in patients with sickle cell disease treated with erythrocyte transfusions. J Pediatr. 1995;126:896–899
  24. Sarnaik S, Soorya D, Kim J, Ravindranath Y, Lusher J. Periodic transfusions for sickle cell anemia and CNS infarction. Am J Dis Child. 1979;133:1254–1257
  25. Cohen AR, Martin MB, Silber JH, Kim HC, Ohene-Frempong K, Schwartz E. A modified transfusion program for prevention of stroke in sickle cell disease. Blood. 1992;79:1657–1661
  26. Wilimas J, Goff JR, Anderson HR, Langston JW, Thompson E. Efficacy of transfusion therapy for one to two years in patients with sickle cell disease and cerebrovascular accidents. J Pediatr. 1980;96:205–208
  27. Ueki K, Meyer FB, Mellinger JF. Moyamoya disease (The disorder and surgical treatment). Mayo Clin Proc. 1994;69:749–757
  28. Ikezaki K, Matsushima T, Kuwabara Y, Suzuki SO, Nomura T, Fukui M. Cerebral circulation and oxygen metabolism in childhood moyamoya disease (A perioperative positron emission tomography study). J Neurosurg. 1994;81:843–850
  29. Matsushima Y, Fukai N, Tanaka K, et al.  A new surgical treatment of moyamoya disease in children (A preliminary report). Surg Neurol. 1981;15:313–320
  30. Matsushima Y, Aoyagi M, Fukai N, Tanaka K, Tsuruoka S, Inaba Y. Angiographic demonstration of cerebral revascularization after encephalo-duro-arterio-synangiosis (EDAS) performed on pediatric moyamoya patients. Bull Tokyo Med Dent Univ. 1982;29:7–17
  31. Tagawa T, Naritomi H, Mimaki T, Yabuuchi H, Sawada T. Regional cerebral blood flow, clinical manifestations, and age in children with moyamoya disease. Stroke. 1987;18:906–910
  32. Soriano SG, Sethna NF, Scott RM. Anesthetic management of children with moyamoya disease. Anesth Analg. 1993;77:1066–1070
  33. Goto Y, Yonekawa Y. Worldwide distribution of moyamoya disease. Neurol Med Chir (Tokyo). 1992;32:883–886
  34. Ikezaki K. Rational approach to treatment of moyamoya disease in childhood. J Child Neurol. 2000;15:350–356
  35. Houkin K, Yoshimoto T, Kuroda S, Ishikawa T, Takahashi A, Abe H. Angiographic analysis of moyamoya disease–how does moyamoya disease progress?. Neurol Med Chir (Tokyo). 1996;36:783–787

    ; discussion 788

  36. Prohovnik I, Pavlakis SG, Piomelli S, et al.  Cerebral hyperemia, stroke, and transfusion in sickle cell disease. Neurology. 1989;39:344–348
  37. Ferrera PC, Curran CB, Swanson H. Etiology of pediatric ischemic stroke. Am J Emerg Med. 1997;15:671–679
  38. Nakashima H, Meguro T, Kawada S, Hirotsune N, Ohmoto T. Long-term results of surgically treated moyamoya disease. Clin Neurol Neurosurg. 1997;99(Suppl. 2):S156–S161
  39. Kuwabara Y, Ichiya Y, Sasaki M, et al.  Cerebral hemodynamics and metabolism in moyamoya disease—a positron emission tomography study. Clin Neurol Neurosurg. 1997;99(Suppl. 2):S74–S78
  40. Takeuchi S, Ishii R, Tsuchida T, Tanaka R, Kobayashi K, Ito J. Cerebral hemodynamics in patients with moyamoya disease. A study of the epicerebral microcirculation by fluorescein angiography. Surg Neurol. 1984;21:333–340
  41. Takeuchi S, Tanaka R, Ishii R, Tsuchida T, Kobayashi K, Arai H. Cerebral hemodynamics in patients with moyamoya disease. A study of regional cerebral blood flow by the 133Xe inhalation method. Surg Neurol. 1985;23:468–474
  42. Matsushima Y, Aoyagi M, Koumo Y, et al.  Effects of encephalo-duro-arterio-synangiosis on childhood moyamoya patients—swift disappearance of ischemic attacks and maintenance of mental capacity. Neurol Med Chir (Tokyo). 1991;31:708–714
  43. Matsushima Y, Inaba Y. Moyamoya disease in children and its surgical treatment. Introduction of a new surgical procedure and its follow-up angiograms. Childs Brain. 1984;11:155–170
  44. Matsushima Y, Aoyagi M, Nariai T, Takada Y, Hirakawa K. Long-term intelligence outcome of post-encephalo-duro-arterio-synangiosis childhood moyamoya patients. Clin Neurol Neurosurg. 1997;99(Suppl. 2):S147–S150
  45. Adelson PD, Scott RM. Pial synangiosis for moyamoya disease in children. Pediatr Neurosurg. 1995;23:26–33
  46. Fujita K, Tamaki N, Matsumoto S. Surgical treatment of moyamoya disease in children (Which is more effective procedure, EDAS or EMS?). Childs Nerv Syst. 1986;2:134–138
  47. Karasawa J, Touho H, Ohnishi H, Miyamoto S, Kikuchi H. Long-term monitoring study after extracranial-intracranial bypass surgery for anterior circulation ischemia in childhood moyamoya disease. J Neurosurg. 1992;77:84–89
  48. Miyamoto S, Kikuchi H, Karasawa J, Nagata I, Yamazoe N, Akiyama Y. Pitfalls in the surgical treatment of moyamoya disease. Operative techniques for refractory cases. J Neurosurg. 1988;68:537–543
  49. Matsushima T, Inoue T, Suzuki SO, Fujii K, Fukui M, Hasuo K. Surgical treatment of moyamoya disease in pediatric patients: Comparison between the results of indirect and direct revascularization procedures. Neurosurgery. 1992;31:401–405
  50. Golby AJ, Marks MP, Thompson RC, Steinberg GK. Direct and combined revascularization in pediatric moyamoya disease. Neurosurgery. 1999;45:50–58

    ; discussion 58-60

  51. Ikezaki K, Fukui M, Inamura T, Kinukawa N, Wakai K, Ono Y. The current status of the treatment for hemorrhagic type moyamoya disease based on a 1995 nationwide survey in Japan. Clin Neurol Neurosurg. 1997;99(Suppl. 2):S183–S186
  52. Farrugia M, Howlett DC, Saks AM. Moyamoya disease. Postgrad Med J. 1997;73:549–552
  53. Chang KH, Yi JG, Han MH, Kim IO. MR imaging findings of moyamoya disease. J Korean Med Sci. 1990;5:85–90
  54. Houkin K, Tanaka N, Takahashi A, Kamiyama H, Abe H, Kajii N. Familial occurrence of moyamoya disease. Magnetic resonance angiography as a screening test for high-risk subjects. Childs Nerv Syst. 1994;10:421–425

PII: S0887-8994(03)00047-X

doi: 10.1016/S0887-8994(03)00047-X

Pediatric Neurology
Volume 29, Issue 2 , Pages 124-130 , August 2003

Article Tools

* Image Usage & Resolution